The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19
Open accessAbstract
The novel coronavirus disease of 2019 (COVID-19) pandemic, as declared by the World Health Organization, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Cardiovascular disease and, in particular, venous thromboembolism (VTE) has emerged as an important consideration in the management of hospitalized patients with COVID-19. The diagnosis of VTE using standardized objective testing is problematic in these patients, given the risk of infecting non-COVID-19 hospitalized patients and hospital personnel, coupled with the usual challenges of performing diagnostic testing in critically-ill patients. Early reports suggest a high incidence of VTE in hospitalized COVID-19 patients, particularly those with severe illness, that is similar to the high VTE rates observed in patients with other viral pneumonias, including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS-CoV).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14817 · Cited by 3,559
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J., Biondi-Zoccai, G., Brown, T. S., Der Nigoghossian, C., Zidar, D. A., Haythe, J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,017
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., & Iba, T. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14810 · Cited by 1,925
Self-citationPrevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Cui, S., Chen, S., Li, X., Liu, S., & Wang, F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14830 · Cited by 1,806
Fox, S. E., Akmatbekov, A., Harbert, J. L., Li, G., Quincy Brown, J., & Vander Heide, R. S. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30243-5 · Cited by 1,526
BARBAR, S., NOVENTA, F., ROSSETTO, V., FERRARI, A., BRANDOLIN, B., PERLATI, M., DE BON, E., TORMENE, D., PAGNAN, A., & PRANDONI, P. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04044.x · Cited by 1,240
Fu, L., Wang, B., Yuan, T., Chen, X., Ao, Y., Fitzpatrick, T., Li, P., Zhou, Y., Lin, Y.-F., Duan, Q., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.041 · Cited by 1,103
Giannis, D., Ziogas, I. A., & Gianni, P. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104362 · Cited by 893
Self-citationSchünemann, H. J., Cushman, M., Burnett, A. E., Kahn, S. R., Beyer-Westendorf, J., Spencer, F. A., Rezende, S. M., Zakai, N. A., Bauer, K. A., Dentali, F., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018022954 · Cited by 819
Acute pulmonary embolism and COVID-19 pneumonia: a random association?
Danzi, G. B., Loffi, M., Galeazzi, G., & Gherbesi, E. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa254 · Cited by 657
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Cohen, A. T., Spiro, T. E., Büller, H. R., Haskell, L., Hu, D., Hull, R., Mebazaa, A., Merli, G., Schellong, S., Spyropoulos, A. C., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1111096 · Cited by 607
Self-citationPredictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE
Spyropoulos, A. C., Anderson, F. A., FitzGerald, G., Decousus, H., Pini, M., Chong, B. H., Zotz, R. B., Bergmann, J.-F., Tapson, V., Froehlich, J. B., et al. (2011) · Chest · doi:10.1378/chest.10-1944 · Cited by 550
Self-citationWang, J., Hajizadeh, N., Moore, E. E., McIntyre, R. C., Moore, P. K., Veress, L. A., Yaffe, M. B., Moore, H. B., & Barrett, C. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14828 · Cited by 536
Hull, R. D., Schellong, S. M., Tapson, V. F., Monreal, M., Samama, M.-M., Nicol, P., Vicaut, E., Turpie, A. G. G., Yusen, R. D., & study*, F. T. E. (. P. F. V. T. I. A. I. M. P. W. P. I. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-1-201007060-00004 · Cited by 384
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
Wang, T., Chen, R., Liu, C., Liang, W., Guan, W., Tang, R., Tang, C., Zhang, N., Zhong, N., & Li, S. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30109-5 · Cited by 376
Ho, K. M., & Tan, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.002690 · Cited by 222
Rosenberg, D., Eichorn, A. M., Alarcon, M., McCullagh, L., McGinn, T. G., & Spyropoulos, A. C. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001152 · Cited by 171
Self-citationObi, A. T., Tignanelli, C. J., Jacobs, B. N., Arya, S., Park, P. K., Wakefield, T. W., Henke, P. K., & Napolitano, L. M. (2019) · Journal of Vascular Surgery: Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2018.08.010 · Cited by 166
Spyropoulos, A. C., Lipardi, C., Xu, J., Peluso, C., Spiro, T. E., Sanctis, Y. D., Barnathan, E. S., & Raskob, G. E. (2020) · TH Open · doi:10.1055/s-0040-1705137 · Cited by 148
Self-citationValidation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients
Greene, M. T., Spyropoulos, A. C., Chopra, V., Grant, P., Kaatz, S., Bernstein, S. J., & Flanders, S. A. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.03.031 · Cited by 104
Self-citationBikdeli, B., Lobo, J. L., Jiménez, D., Green, P., Fernández‐Capitán, C., Bura-Rivière, A., Otero, R., Tullio, M. R. D., Galindo, S., Ellis, M. H., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009042 · Cited by 68
Emergence of institutional antithrombotic protocols for coronavirus 2019
Cohoon, K. P., Mahé, G., Tafur, A. J., & Spyropoulos, A. C. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12358 · Cited by 57
Self-citation
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Self-citationExtrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis
Nopp, S., Moik, F., Jilma, B., Pabinger, I., & Ay, C. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12439 · Cited by 489
Lopes, R. D., de Barros e Silva, P. G. M., Furtado, R. H. M., Macedo, A. V. S., Bronhara, B., Damiani, L. P., Barbosa, L. M., de Aveiro Morata, J., Ramacciotti, E., de Aquino Martins, P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01203-4 · Cited by 481
Cuker, A., Tseng, E. K., Nieuwlaat, R., Angchaisuksiri, P., Blair, C., Dane, K., Davila, J., DeSancho, M. T., Diuguid, D., Griffin, D. O., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003763 · Cited by 408
Metadata
- Authors
- Spyropoulos, A. C., Levy, J. H., Ageno, W., Connors, J. M., Hunt, B. J., Iba, T., Levi, M., Samama, C. M., Thachil, J., Giannis, D., & Douketis, J. D.
- Venue
- Journal of Thrombosis and Haemostasis
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 18
- Issue
- 8
- Pages
- 1859-1865
- ISSN
- 1538-7836 (ISSN-L)
- OpenAlex
- W3029923949
- Cited by
- 657
- References
- 29
- FWCI
- 77.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
